Evidence map›Paper›PMID 41553816›Full record

ArticleTrends in hearing

The Effect of Real Ear Target Deviations on SSQ and Speech Intelligibility in a Clinical Population.

Simon E Lansbergen, Gertjan Dingemanse, Niek J Versfeld, Wouter A Dreschler, André Goedegebure

Abstract read
In one paragraph

Article in Trends in hearing. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Simon E LansbergenDepartment of Otorhinolaryngology and Head and Neck Surgery, Erasmus MC University Medical Center Rotterdam, Rotterdam, The Netherlands.ORCID 0000-0001-6941-084X
Gertjan DingemanseDepartment of Otorhinolaryngology and Head and Neck Surgery, Erasmus MC University Medical Center Rotterdam, Rotterdam, The Netherlands.ORCID 0000-0001-8837-3474
Niek J VersfeldOtorhinolaryngology - Head and Neck Surgery, Amsterdam UMC Location VUmc, Amsterdam, The Netherlands.
Wouter A DreschlerDepartment of Clinical and Experimental Audiology, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands.
André GoedegebureDepartment of Otorhinolaryngology and Head and Neck Surgery, Erasmus MC University Medical Center Rotterdam, Rotterdam, The Netherlands.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The quality of hearing-aid (HA) fitting is typically evaluated using speech intelligibility tests and/or Real-Ear Measurements (REMs). Although it is assumed that a better fit improves daily outcomes, supporting evidence is inconclusive. This study examined whether deviations from National Acoustic Laboratories Non-Linear (NAL-NL2) real-ear targets (real-ear-to-target difference, RTD) predicted changes in Speech, Spatial, and Qualities of Hearing Scale (SSQ) scores, and whether they related to aided speech recognition in quiet. The effects of hearing loss and patient characteristics were also considered. Data from 298 adults (mean age 65 years) fitted with new or replacement HAs (66%) were analyzed. Baseline measures included unaided speech recognition in quiet and a 17-item SSQ; follow-up measures included aided speech recognition in quiet, RTDs, and the SSQ. Principal Components Analysis summarized RTDs into overall gain (RTD

Indexed as

Correction of Hearing ImpairmentHearing AidsPersons with Hearing DisabilitiesSpeech IntelligibilitySpeech PerceptionAcoustic StimulationAdultAgedAged, 80 and overAudiometry, Pure-ToneAuditory AcuityAuditory ThresholdFemaleHumansMaleMiddle Agedhearing aidNAL-NL2PROMrehabilitationREM

Identifiers

PMID41553816
PMCPMC12816552

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.